Argen X Se Adr (ARGX)

Feb 28, 2025

Argenx Benefits From Multiple Approved Indications of Vyvgart and Strong Uptake - Morningstar

Feb 28, 2025

Feb 28, 2025

Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer Says -February 28, 2025 at 11:05 am EST - Marketscreener.com

Feb 28, 2025

Feb 28, 2025

H.C. Wainwright lifts argenx stock price target to $720 By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 28, 2025

H.C. Wainwright lifts argenx stock price target to $720 - Investing.com

Feb 28, 2025

Feb 28, 2025

Argenx stock target raised to $701 by JMP on VYVGART strength - Investing.com

Feb 28, 2025

Feb 27, 2025

Argenx stock target lifted to $761 by TD Cowen, maintains buy - Investing.com India

Feb 27, 2025

Feb 27, 2025

Argenx’s VYVGART Franchise Drives Strong Performance and Growth Prospects - TipRanks

Feb 27, 2025

Feb 27, 2025

argenx ADR earnings beat by $10.57, revenue topped estimates - Investing.com South Africa

Feb 27, 2025

Feb 27, 2025

Argenx Q4 Swings to Earnings, Operating Income Increases -February 27, 2025 at 04:00 am EST - Marketscreener.com

Feb 27, 2025

Feb 27, 2025

Immunology Company argenx Swings to Profit in FY24; Net Sales Climb -February 27, 2025 at 01:24 am EST - Marketscreener.com

Feb 27, 2025

Feb 27, 2025

Argenx: $737 Million In Q4 Global Product Net Sales -February 27, 2025 at 01:14 am EST - Marketscreener.com

Feb 27, 2025

Feb 19, 2025

Argenx Vaults 3,659% With Profit Growth Seen In Triple Digits; Earnings Next As Stock Hits Highs - Investor's Business Daily

Feb 19, 2025

Feb 07, 2025

BBVA Argentina ADR (BBAR) Shares Rise Despite Market Challenges - The News Heater

Feb 07, 2025

Feb 07, 2025

Telecom Argentina S.A. ADR (TEO) Stock Records 32.38% Quarterly Movement - The News Heater

Feb 07, 2025

Feb 06, 2025

Guru Fundamental Report for ARGXBenjamin Graham - Nasdaq

Feb 06, 2025

Feb 03, 2025

Orphan Designated Drugs Market Analysis: Key Trends, Players and Forecasts for Future Growth - GlobeNewswire Inc.

Feb 03, 2025

Jan 30, 2025

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jan 30, 2025

Jan 29, 2025

argenx SE : The stock is approaching a major resistance level -January 29, 2025 at 04:11 am EST - Marketscreener.com

Jan 29, 2025

Jan 15, 2025

argenx's SWOT analysis: biotech stock soars on VYVGART success, pipeline promise - Investing.com India

Jan 15, 2025

Jan 14, 2025

Argenx stock price target raised to $717 by H.C. Wainwright - Investing.com India

Jan 14, 2025

Jan 14, 2025

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Jan 14, 2025

Jan 13, 2025

Truist Securities raises argenx stock rating to Buy, says will exceed Vision 2030 - Investing.com

Jan 13, 2025

Jan 13, 2025

Jefferies raises argenx stock target, reaffirms buy on global sales result - Investing.com

Jan 13, 2025

Jan 07, 2025

argenx's SWOT analysis: biotech stock soars on vyvgart success - Investing.com

Jan 07, 2025

Jan 07, 2025

Piper Sandler increases argenx stock price target on revised estimates - Investing.com

Jan 07, 2025

Jan 06, 2025

Argenx stock soars to all-time high of $645.31 amid robust growth - Investing.com

Jan 06, 2025

Dec 28, 2024

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment - Yahoo Finance

Dec 28, 2024

Dec 23, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 23, 2024

Dec 16, 2024

Argenx stock soars to all-time high of $630.4 amid robust growth By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 16, 2024

Argenx stock soars to all-time high of $630.4 amid robust growth - Investing.com

Dec 16, 2024

Dec 15, 2024

argenx's SWOT analysis: biotech stock soars on VYVGART success - Investing.com

Dec 15, 2024

Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - MSN

Dec 12, 2024

Dec 09, 2024

Argenx Expands Autoimmune Portfolio With Additional Vyvgart Approvals as Pipeline Develops - Morningstar

Dec 09, 2024

Dec 09, 2024

Piper Sandler maintains stock target on argenx, cites growth potential - Investing.com

Dec 09, 2024

Dec 02, 2024

Argenx stock soars to all-time high of $620.29 - Investing.com

Dec 02, 2024

Nov 30, 2024

10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey

Nov 30, 2024

Nov 26, 2024

Argenx stock soars to all-time high of $612.64 amid robust growth By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 26, 2024

Argenx stock soars to all-time high of $612.64 amid robust growth - Investing.com India

Nov 26, 2024

Nov 25, 2024

argenx's SWOT analysis: biotech firm's stock soars on VYVGART success - Investing.com

Nov 25, 2024

Nov 25, 2024

Jefferies reaffirms Buy rating on argenx stock, ups target amid promising trial updates - Investing.com India

Nov 25, 2024

Nov 21, 2024

Can Argenx stock sustain its autoimmune category dominance? Oppenheimer weighs in - Investing.com

Nov 21, 2024

Nov 21, 2024

Barclays bullish on argenx stock after positive trial results - Investing.com

Nov 21, 2024

Nov 21, 2024

Barclays bullish on argenx stock after positive trial results By Investing.com - Investing.com South Africa

Nov 21, 2024

Nov 20, 2024

argenx shares see price target boosted by Raymond James, Strong Buy rating upheld - Investing.com

Nov 20, 2024